Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Addiction Neuroscience|June 30, 2023
No evidence of accelerated epigenetic aging among black heroin users: A case vs control analysisJermaine D Jones, Suky Martinez, Ingrid Gonzalez, et al.
The American Journal on Addictions|November 22, 2017
Chronic pain and opioid abuse: Factors associated with health-related quality of lifeJermaine D Jones, Jonathan S Vogelman, Rachel Luba, et al.
Addiction Neuroscience|September 19, 2022
The subjective experience of heroin effects among individuals with chronic opioid use: Revisiting reinforcement in an exploratory studySuky Martinez, Laura Brandt, Sandra D Comer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 29, 2010
The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxoneJermaine D Jones, Maria A Sullivan, Jeanne Manubay, et al.
Pharmacology, Biochemistry, and Behavior|April 21, 2009
Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversionJermaine D Jones, F Scott Hall, George R Uhl, et al.
Drug and Alcohol Dependence|July 6, 2024
Empirical assessment of wounds among people who use substancesJermaine D Jones, Michael Chaple, Stephanie Rozen, et al.
Drug and Alcohol Dependence|June 9, 2015
Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin usersJermaine D Jones, Jared J Atchison, Gabriela Madera, et al.
Drug and Alcohol Review|November 3, 2020
The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivitySuky Martinez, Jermaine D Jones, Nehal P Vadhan, et al.
Drug and Alcohol Dependence|September 12, 2017
Glial and neuroinflammatory targets for treating substance use disordersRyan K Bachtell, Jermaine D Jones, Keith G Heinzerling, et al.
The American Journal of Drug and Alcohol Abuse|February 21, 2013
Opioid-like effects of the neurokinin 1 antagonist aprepitant in patients maintained on and briefly withdrawn from methadoneJermaine D Jones, Taylor Speer, Sandra D Comer, et al.
Pageof 7